Clinical management of thrombophilia-related placental vascular complications
- 1 June 2004
- journal article
- case report
- Published by American Society of Hematology in Blood
- Vol. 103 (11), 4003-4009
- https://doi.org/10.1182/blood-2003-08-2744
Abstract
Pregnancy is a hypercoagulable state with an increased thrombotic risk throughout gestation and the postpartum period. Women with thrombophilia may have a further increased risk of placental vascular complications, including pregnancy loss, preeclampsia, intrauterine growth restriction, and placental abruption. Preliminary data suggest that maternal antithrombotic prophylaxis may result in improved gestational outcome. Randomized trials are under way and hopefully will optimize maternal and neonatal outcome.Keywords
This publication has 50 references indexed in Scilit:
- Haemostatic changes in pregnancyBest Practice & Research Clinical Haematology, 2003
- Antiphospholipid antibodies and pregnancyBest Practice & Research Clinical Haematology, 2003
- How we manage venous thromboembolism during pregnancyBlood, 2002
- Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastageFertility and Sterility, 2002
- Reference interval of D-dimer in pregnant womenClinical Biochemistry, 2001
- Increased fetal loss in women with heritable thrombophiliaThe Lancet, 1996
- Development of resistance to activated protein C during pregnancyBritish Journal of Haematology, 1995
- Recurrent Miscarriage: Epidemiologic Factors, Definitions, and IncidenceClinical Obstetrics and Gynecology, 1994
- Fibrinolysis in pregnancy: a study of plasminogen activator inhibitorsBlood, 1987
- Functional and immunologic protein S levels are decreased during pregnancyBlood, 1986